| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Director | Common Stock | 50.6K | $3.34M | $66.05 | 18 Nov 2025 | By Andrew W. Lo and Nancy N. Lo JTWROS |
| BridgeBio Pharma, Inc. | Director | Common Stock | 14.1K | $945K | $67.06 | 17 Nov 2025 | Direct |
| Roivant Sciences Ltd. | Director | Common Shares | 52.1K | $540K | $10.35 | 15 Sep 2022 | Direct |
| AbCellera Biologics Inc. | Director | Share option (right to buy) | 541K | 12 Jun 2025 | Direct | ||
| Roivant Sciences Ltd. | Director | Stock Option (Right to Buy) | 71.9K | 15 Sep 2022 | Direct | ||
| BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 8.43K | 20 Jun 2025 | Direct |